# Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients

> **NCT01844648** · PHASE2 · COMPLETED · sponsor: **NeuroHealing Pharmaceuticals Inc.** · enrollment: 30 (actual)

## Conditions studied

- Sialorrhea (Excessive Drooling)

## Interventions

- **DRUG:** NH004 tropicamide
- **DRUG:** NH004 Placebo

## Key facts

- **NCT ID:** NCT01844648
- **Lead sponsor:** NeuroHealing Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-10
- **Final completion:** 2015-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01844648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01844648, "Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01844648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*